PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI
PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI
Active, not recruiting · NCT05154162 · Registry updated 2026-03-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2026-03-03 | NCT05154162 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peter MacCallum Cancer Centre, Australia | 48 |
| St Vincent's Hospital, Sydney | 9 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Austin Health | Melbourne | Australia | 16 |
| Cabrini Health | Melbourne | Australia | 3 |
| Peter MacCallum Cancer Centre | Melbourne | Australia | 149 |
| Royal Adelaide Hospital | Adelaide | Australia | 132 |
| Royal Brisbane and Women's Hospital | Brisbane | Australia | 5 |
| St Vincent's Hospital | Sydney | Australia | 12 |